Here's the live share price of Caplin Point Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Caplin Point Laboratories | 11.69 | 10.50 | 38.34 | 70.88 | 31.54 | 37.96 | 27.36 |
| Sun Pharmaceutical Industries | -1.10 | -2.57 | 6.47 | 6.51 | 19.08 | 19.65 | 19.36 |
| Divi's Laboratories | -1.82 | 8.98 | 37.39 | 43.00 | 51.42 | 35.81 | 11.82 |
| Torrent Pharmaceuticals | -3.67 | -2.96 | 9.76 | 11.41 | 35.48 | 38.43 | 25.38 |
| Zydus Lifesciences | -5.56 | 0.90 | 2.95 | 22.59 | 10.54 | 21.79 | 15.02 |
| Cipla | -2.33 | -4.48 | -1.12 | 4.45 | -10.83 | 3.79 | 7.82 |
| Laurus Labs | -4.92 | -0.15 | 27.16 | 75.93 | 108.84 | 67.07 | 22.74 |
| Lupin | -2.94 | -11.53 | -6.93 | -9.49 | 8.55 | 24.38 | 16.53 |
| Dr. Reddy's Laboratories | -2.02 | -1.70 | -9.69 | -12.11 | -9.03 | 0.64 | 3.26 |
| Mankind Pharma | -2.47 | -5.03 | -0.36 | 4.63 | -8.74 | 9.97 | 10.33 |
| Aurobindo Pharma | 0.20 | 2.47 | 13.04 | 34.88 | 58.30 | 26.36 | 16.97 |
| Glenmark Pharmaceuticals | -3.59 | 7.96 | 12.08 | 15.01 | 18.19 | 47.18 | 35.27 |
| Biocon | -3.44 | -6.53 | -3.59 | 2.75 | 9.19 | 15.01 | 1.91 |
| Alkem Laboratories | -3.06 | -8.41 | -1.23 | -6.46 | -2.81 | 12.43 | 6.28 |
| Abbott India | -0.66 | -5.81 | 0.40 | -5.34 | -16.22 | 5.35 | 5.90 |
| Anthem Biosciences | 3.26 | 12.62 | 22.06 | 39.57 | 12.08 | 8.39 | 4.95 |
| GlaxoSmithKline Pharmaceuticals | -4.60 | 15.45 | 36.79 | 19.58 | 6.96 | 27.64 | 14.60 |
| Ipca Laboratories | 0.73 | 11.21 | 19.59 | 31.01 | 47.16 | 30.68 | 9.48 |
| Gland Pharma | 1.61 | 15.19 | 29.06 | 72.00 | 54.87 | 19.73 | -5.98 |
| Ajanta Pharma | -2.66 | 0.75 | 16.35 | 16.47 | 32.60 | 26.31 | 18.64 |
Source: Dion Global
Over the last one year, Caplin Point Laboratories has gained 31.54% compared to peers like Sun Pharmaceutical Industries (19.08%), Divi's Laboratories (51.42%), Torrent Pharmaceuticals (35.48%). From a 5 year perspective, Caplin Point Laboratories has outperformed peers relative to Sun Pharmaceutical Industries (19.36%) and Divi's Laboratories (11.82%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 2,719.19 | 2,736.04 |
| 10 | 2,614.16 | 2,664.8 |
| 20 | 2,577.6 | 2,611.31 |
| 50 | 2,578.23 | 2,520.33 |
| 100 | 2,301.03 | 2,357.87 |
| 200 | 2,042.26 | 2,188.65 |
Source: Dion Global
In the latest quarter, Caplin Point Laboratories remained same as its previous close in promoter holding, while DII stake increased to 2.49%, FII holding fell to 5.76%, and public shareholding moved up to 21.19% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 3,00,099 | 1.18 | 75.53 | |
| 2,58,326 | 0.96 | 65.02 | |
| 2,15,000 | 3.95 | 54.11 | |
| 1,02,295 | 0.54 | 25.75 |
Source: Dion Global
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Sep 04, 2026, 08:27 PM IST IST | Caplin Point Lab. - Letter To Shareholders |
| Sep 03, 2026, 06:24 AM IST IST | Caplin Point Lab. - Business Responsibility and Sustainability Reporting (BRSR) |
| Sep 03, 2026, 06:17 AM IST IST | Caplin Point Lab. - Notice Of The 35Th Annual General Meeting |
| Sep 03, 2026, 06:08 AM IST IST | Caplin Point Lab. - Reg. 34 (1) Annual Report. |
| Sep 01, 2026, 11:34 PM IST IST | Caplin Point Lab. - General Updates |
Source: Dion Global
Caplin Point Laboratories Ltd. is a Public Limited Listed company incorporated on 16/04/1990 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification Number(CIN) is L24231TN1990PLC019053 and registration number is 019053. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 738.33 Cr. and Equity Capital is Rs. 15.20 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Caplin Point Laboratories is ₹2,810.25 as on Sep 04, 2026.
The Caplin Point Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
The market cap of Caplin Point Laboratories is ₹21,361.19 Cr as on Sep 04, 2026.
Today’s highest and lowest price of Caplin Point Laboratories are ₹2,867.10 and ₹2,759.05.
The 52-week high/low is the highest and lowest price at which Caplin Point Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Caplin Point Laboratories is ₹2,874.00 and 52-week low of Caplin Point Laboratories is ₹1,502.45 as on Sep 04, 2026.
The Caplin Point Laboratories has shown returns of -1.86% over the past day, 8.54% for the past month, 38.49% over 3 months, 31.99% over 1 year, 37.63% across 3 years, and 27.18% over 5 years.
P/E ratio of and PB ratio of Caplin Point Laboratories are 32.11 and 5.67 on Sep 04, 2026. While the company gives a dividend yield of 0.28 per annum.
Source: Dion Global